A high impact on quality of life combined with their enormous incidence and prevalence put ocular diseases among the leading healthcare issues of modern times. For instance, approximately 200,000 intravitreal injections for age-related macular degeneration (AMD) were performed in Austria in 2022, with numbers projected to rise to over 300,000 annually by 2030
1. In the United States, anti-VEGF agents for AMD treatment comprise 10% of the total Medicare Part B drug budget, representing one of the most expensive therapies in modern medicine [
1]. Cataract surgery, as another example of superlatives, stands as the most common surgical procedure in medicine overall. It is thus worth taking a closer look at current trends in ophthalmology that potentially influence the medical world beyond just eye care. …
